CVS Health reportedly seeking to acquire Oak Street Health for $10B

CVS Health is exploring a sale of Oak Street Health, a primary care provider for Medicare patients, in a deal that could fetch $10 billion. The news was first reported by Bloomberg, which cited people familiar with the matter.

Currently, talks are ongoing between the two companies. The $10 billion figure also includes Oak Street Health’s debt, and the company currently has a market value of $5.5 billion. Oak Street operates 169 centers in the United States, caring for 159,000 patients. According to Bloomberg, private equity firms General Atlantic and Newlight Partners collectively own roughly 39% of Oak Street Health.

The purported deal comes after CVS Health, which operates nearly 10,000 retail pharmacy stores, announced in 2022 it would acquire home healthcare company Signify Health for $8 billion. That deal is expected to close in the first half of 2023. Both deals move CVS Health, which also owns health insurer Aetna, squarely into the healthcare services provider field. The retail pharmacy chain has operated clinics within its stores for many years, but its recent massive acquisitions will extend the brand’s reach in the type of services offered.

The news also comes just after Oak Street Health appointed its first-ever chief wellness officer, creating the position to support provider wellness. Oak Street Health’s provider strategy includes a high-touch approach with patients.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”